EXCLUSIVE: Deadline can reveal the first trailer for László Nemes’ post-World War II Hungarian family drama Orphan, which ...
Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis results for crofelemer in the prespecified subgroup of ...
AAVB-039 addresses the root cause of the disease, benefitting patients with any ABCA4 mutation AAVB-039 is currently being assessed in the CELESTE interventional clinical trial and we continue ...
For the first time ever, the World Orphan Drug Congress Europe is heading to Amsterdam, bringing together over 2,000 attendees from around the world to explore the latest advancements, opportunities, ...
Practice, practice, practice. The phrase is typically associated with athletic and artistic endeavors, but no matter the subject, the long version is: The more one practices, the better one gets. It’s ...
Bullying often has unexpected consequences, as one mean girl discovered when she targeted the wrong orphan. This video captures the confrontation, the reactions, and the lesson about courage and ...
The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. In what they are calling a “two-birds-one-stone” approach, researchers at Iowa State University have ...
COEUR D'ALENE, Idaho — Looking for something to do this weekend? Look no further than the family-friendly Coeur d’Alene Oktoberfest event. Oktoberfest originated in Germany back in 1810, featuring a ...
MONMOUTH, N.J., Sept. 18, 2025 /PRNewswire/ -- J & D Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company's ...
Laszlo Nemes’ “Orphan,” which had its world premiere in Venice Film Festival’s competition section, has been selected as the Hungarian submission for the best international feature film Oscar at the ...
Shares of Beyond Air gained after its subsidiary received orphan drug designation from the Food and Drug Administration for a brain cancer treatment. The stock climbed 57% to $3.48 on Monday. Shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results